Estrella Immunopharma, Inc. (ESLA)
0.39
-0.02
(-4.90%)
USD |
NASDAQ |
Nov 06, 10:23
Estrella Immunopharma EPS Diluted (Quarterly) : -0.0536 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0536 |
| March 31, 2026 | -0.0544 |
| December 31, 2025 | -0.0162 |
| September 30, 2025 | -0.1294 |
| June 30, 2025 | -0.1533 |
| March 31, 2025 | -0.0582 |
| December 31, 2024 | -0.029 |
| September 30, 2024 | -0.0933 |
| June 30, 2024 | -0.1079 |
| March 31, 2024 | -0.0132 |
| December 31, 2023 | -0.029 |
| Date | Value |
|---|---|
| September 30, 2023 | -1.777 |
| June 30, 2023 | -0.0326 |
| March 31, 2023 | -0.0272 |
| December 31, 2022 | -0.0646 |
| September 30, 2022 | -0.059 |
| June 30, 2022 | -0.0615 |
| March 31, 2022 | -0.0242 |
| December 31, 2021 | -0.0232 |
| September 30, 2021 | -0.0184 |
| June 30, 2021 | -0.0006 |
| February 28, 2021 | -0.0001 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.306M |
| Total Expenses (Quarterly) | 2.306M |
| Enterprise Value | 17.50M |
| Earnings Yield | -65.03% |
| Normalized Earnings Yield | -63.64 |